Lymphoma Therapy
Studies from University of Wisconsin, Comprehensive Cancer Center in the area of lymphoma therapy published
Published in Cancer Weekly, June 5th, 2007
Data detailed in "A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas" have been presented. "Burkitt lymphoma (BL) and Burkitt-like lymphomas (BLL) are clinically and biologically aggressive B-cell malignancies. Brief-duration, high intensity multidrug regimens with central nervous system (CNS) prophylaxis have proven to be effective, with published series of adult patients documenting complete response (CR) rates of 80 to 100 percent and 2-year event-free survival (EFS) rates ranging from 60 to 90 percent," scientists writing in the journal Cancer Investigation report.
"Based upon the known...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-06-05)
More Articles from Cancer Weekly
- Bird Flu
Wistar Institute Launches New Vaccine Center - Cancer Gene Therapy
Dyson Foundation Gives $5 Million for Ophthalmology Research - Cancer Vaccines
Hospital Buys Downtown City Block to Complete Research Campus - Cancer Vaccines
Majority of U.S. Parents Not in Favor of HPV Vaccine Mandates - Bird Flu
CEL-SCI Presents Long-Term Cancer Survival Data With Multikine - Bladder Cancer
Viventia Biotech reports final Vicinium Phase I/II bladder cancer data at the American Urological Association Annual Meeting - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
